Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi

NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi The UK’s National Institute for Health and Care Excellence (NICE) says it cannot recommend Bayer’s tumour-agnostic drug Vitrakvi at its current price, but remain ‘open’ for further discussion. . ... Although Bayer has had a head start in the EU

Newly-listed BioNTech buys Neon to boost cell therapy assets

Newly-listed BioNTech buys Neon to boost cell therapy assets German biotech has agreed to pay $67m in the deal

Bayer bulks up in women’s health again with non-hormonal contraceptive deal

Bayer bulks up in women’s health again with non-hormonal contraceptive deal If approved candidate would become a first-in-category therapy. Bayer’s partnering spree shows no sign of letting up, as it agrees a licensing deal with Daré Bioscience for a ... We believe Bayer is best positioned to maximise the market opportunity

Case study: Tackle TD for Bayer UK

Case study: Tackle TD for Bayer UK seeded out at intervals throughout the year to a highly targeted audience via paid media on the Bayer Facebook and YouTube channels. ... Using such a high profile celebrity on digital media was a first for Bayer UK.

FDA clears Blueprint’s $32k-per-month GI cancer drug

FDA clears Blueprint’s $32k-per-month GI cancer drug imatinib) and Pfizer’s Sutent (sunitinib), which are also available as generics, and Bayer’s Stivarga (regorafenib) which is still in patent.

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials specialises in delivering effective global patient recruitment strategies for your clinical trials by adopting a patient and site-centric...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...